tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
US Market

Corvus Pharmaceuticals (CRVS) Income Statement

Compare
579 Followers

Corvus Pharmaceuticals Income Statement

Last quarter (Q3 2024), Corvus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Corvus Pharmaceuticals's net income was $-40.22M. See Corvus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -151.00K$ -367.00K$ -460.00K$ -632.00K$ -743.00K
Operating Expenses
$ 23.26M$ 32.56M$ 38.63M$ 43.76M$ 48.85M
Depreciation and Amortization
$ 151.00K$ 367.00K$ 460.00K$ 632.00K$ 743.00K
EBITDA
$ -26.88M$ -40.94M$ -42.78M$ -5.36M$ -48.85M
Operating Income
$ -23.41M$ -32.56M$ -38.63M$ -43.76M$ -48.85M
Other Income/Expenses
$ -3.62M$ -8.74M$ -4.61M$ 37.77M$ 2.18M
Pretax Income
$ -27.03M$ -41.31M$ -43.24M$ -6.00M$ -46.67M
Net Income
$ -27.03M$ -50.05M$ -38.20M$ -4.82M$ -43.75M
Per Share Metrics
Basic EPS
$ -0.56$ -1.08$ -0.91$ -0.16$ -1.49
Diluted EPS
$ -0.56$ -1.08$ -0.91$ -0.16$ -1.49
Weighted Average Shares Outstanding
48.03M 46.55M 41.85M 29.48M 29.35M
Weighted Average Shares Outstanding (Diluted)
48.03M 46.55M 41.85M 29.48M 29.35M
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis